鼻气道炎症反应和病原体检测在患有囊性纤维化的婴儿
Benjamin T Kopp1, Sydney E Ross2, Dinesh Bojja1
1Division of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, GA, USA; Children's Healthcare of Atlanta, Atlanta, GA, USA.
概括
鼻液分析可以检测患有囊性纤维化 (CF) 的婴儿的呼吸道炎症. 炎症标志物如IL-6和中性粒细胞弹性酶 (NE) 在病毒感染和肺部恶化 (PEx) 期间增加.
科学领域:
- 儿科肺病学 儿科肺病学
- 炎症生物标志物 炎症生物标志物
- 囊性纤维化研究 囊性纤维化研究
背景情况:
- 在患有囊性纤维化 (CF) 的婴儿中,非侵入性检测呼吸道炎症是具有挑战性的.
- 假设鼻液中的炎症标志物表明病毒感染或肺部恶化 (PEx) 期间的炎症.
研究的目的:
- 在患有CF的婴儿的鼻液中测量炎症标记物 (IL-1β,IL-6,IL-8,IL-10,IL-17A,中性粒细胞弹性酶 (NE),TNF-α).
- 评估这些标志物是否与病毒感染,PEx或环境暴露如烟雾相关.
主要方法:
- 收集了34名患有CF的婴儿的鼻液,拭子和头发.
- 分析了鼻液的细胞因子和鼻的呼吸道病毒.
- 在头发样本中测量尼古丁,并根据病毒状况,PEx和烟雾暴露,比较细胞因子水平.
主要成果:
- 在患有呼吸道病毒的婴儿中观察到IL-6,IL-8,TNF-α和NE的度增加.
- 在患有病毒感染和PEx的婴儿中,IL-17A降低.
- 在可检测尼古丁水平的婴儿中发现IL-6,IL-10和NE水平升高.
结论:
- 非侵入性鼻液采集是一种可行的方法,用于识别患有CF的婴儿的呼吸道炎症.
- 这种方法可以帮助监测与临床变化和环境暴露相关的炎症.
更多相关视频
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
30.4K
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
1.5K
相关概念视频
Cystic Fibrosis: Pathogenesis
252
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
252
Cystic Fibrosis: Management
172
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
172
